MedTrace Logo

Meta Self-efficacy Internet Intervention to Improve Work Self-efficacy and Occupational Well-being in Young Employees

NCT06944990 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-04-25

No results posted yet for this study

Summary

This randomized controlled trial aims to test whether enhancing meta self-efficacy through a self-guided internet intervention improves young employees' work self-efficacy and occupational well-being. The trial will evaluate primary (work self-efficacy) and secondary (three dimensions of occupational well-being) outcomes. It is hypothesized that boosting meta self-efficacy will lead to improvements in outcomes, with effects assessed immediately after the intervention, and at 3- and 6-month follow-ups.

Conditions

  • Self Efficacy
  • Occupational Stress
  • Well-Being, Psychological
  • Work Related Stress

Interventions

BEHAVIORAL

Meta self-efficacy internet intervention

The meta self-efficacy intervention is a three-week program comprised of activities designed to enhance meta self-efficacy (the ability to leverage self-efficacy sources). The intervention is contextualized to young employees.

BEHAVIORAL

Placebo

The placebo condition contains educational material delivered with the same modality as in the experimental condition.

Sponsors & Collaborators

  • University of Social Sciences and Humanities, Warsaw

    lead OTHER

Principal Investigators

  • Jan Maciejewski · SWPS University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2027-12-01
Completion
2027-12-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06944990 on ClinicalTrials.gov